Delivery Order SPE2DB22D9239-SPE2DB25FDL94
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems on August 21, 2025, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this firm fixed-price delivery order, which carries no set-aside designation. This award represents a discrete delivery order issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,019.25 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a purchase under DLA's larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing the woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,246.20 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on June 17, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Mirena is a long-acting reversible contraceptive device, consistent with DMS Pharmaceutical Group's portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with an ultimate completion date of September 17, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. The place of performance is Park Ridge, Illinois, where DMS...
- The Defense Logistics Agency awarded a $16,612.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a specific product requisition under DMS's larger indefinite delivery contract with DLA, which is valued at...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL94Delivery Order
The Defense Logistics Agency (DLA) awarded a $15,623.10 delivery order to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, effective September 17, 2025, with an ultimate completion date of October 8, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its primary location. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The Mirena system is a contraceptive device commonly used within military and federal healthcare systems to support reproductive health services across Department of Defense medical facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets. The company maintains a robust portfolio of pharmaceutical product deliveries, spanning prescription medications, biologics, medical consumables, and specialty products to military health facilities nationwide. This award reflects the company's ongoing role as a primary vendor for DLA's pharmaceutical and medical supply distribution requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 9/17/25 |